Neurocrine Biosciences (NasdaqGS:NBIX) FY Conference December 02, 2025 09:30 AM ET Company ParticipantsEric Benevich - CCOMatt Abernethy - CFOConference Call ParticipantsDavid Amsellem - AnalystDavid AmsellemAll right.Matt AbernethyOkay, we're live now.David AmsellemWe are live.Matt AbernethyThat's awesome.David AmsellemAll right.Matt AbernethyOutside chat.David AmsellemLet's kick things off. This is David Amsellem from the Piper Sandler Biopharma Research Team. We're delighted to have Neurocrine here. We h ...